Kinetic theory of fibrillogenesis of amyloid beta-protein. - Wikidata - awgldk - TriplyDB

Kinetic theory of fibrillogenesis of amyloid beta-protein.

Kinetic theory of fibrillogenesis of amyloid beta-protein.

http://www.wikidata.org/entity/Q36298130

about

Vitamin A and Alzheimer's disease Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences Dementia of the eye: the role of amyloid beta in retinal degeneration Dynamics of the formation of a hydrogel by a pathogenic amyloid peptide: islet amyloid polypeptide.The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease Stepwise dynamics of epitaxially growing single amyloid fibrils.Contrasting effects of nanoparticle-protein attraction on amyloid aggregation Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis Characterization of oligomers of heterogeneous size as precursors of amyloid fibril nucleation of an SH3 domain: an experimental kinetics study.Induced beta-barrel formation of the Alzheimer's Abeta25-35 oligomers on carbon nanotube surfaces: implication for amyloid fibril inhibition A single mutation in an SH3 domain increases amyloid aggregation by accelerating nucleation, but not by destabilizing thermodynamically the native state.Self-assembly of human latexin into amyloid-like oligomers.Ultrafast colorimetric determination of predominant protein structure evolution with gold nanoplasmonic particles.Structural differences between Abeta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange.Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway Ultrasonic force microscopy for nanomechanical characterization of early and late-stage amyloid-β peptide aggregation.Structural classification of toxic amyloid oligomers Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity.Concentration effect on the aggregation of a self-assembling oligopeptide.Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution.Kinetic control of dimer structure formation in amyloid fibrillogenesis A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea.Biophysical studies of the development of amyloid fibrils from a peptide fragment of cold shock protein B.Polymorphic fibril formation by residues 10-40 of the Alzheimer's beta-amyloid peptide.Benchmarking implicit solvent folding simulations of the amyloid beta(10-35) fragment Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide.Role of small oligomers on the amyloidogenic aggregation free-energy landscape Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.In vitro polymerization of a functional Escherichia coli amyloid protein.Mathematical modeling for the pathogenesis of Alzheimer's disease.Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Structure determination of micelle-like intermediates in amyloid beta -protein fibril assembly by using small angle neutron scattering Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.Therapeutic protein aggregation: mechanisms, design, and control.

P2860

Q22242414-321F340C-FC4C-449E-8E5B-F4BD07BB9134 Q24653927-3165FA42-ABF7-4586-B7BB-C5962460F968 Q26828978-682F59CC-9F74-43A0-849C-7AE19A52C7F0 Q27314943-40FCC0EB-8455-41ED-BCB7-8ADAC3CF450C Q28287224-658A160F-2124-4B5A-A01E-503165330D6A Q28346218-F0E45526-89D9-4C78-ABD8-31636ABD4265 Q28363291-EE77F478-2591-4E09-98AC-0A9A535F6CA6 Q28383347-D8419914-A245-41D6-989B-9AA3BBB8F414 Q28389698-B256A590-8FA0-46FC-9F7F-4E11FF701F45 Q28587217-CF56F80E-C310-4765-81D2-DB758F4AA90B Q30009965-EC6C41FD-8F02-485B-81FE-35321E928A0B Q30157126-138A4662-4577-445B-B39B-154C9E7194CC Q30157375-2C51FD2F-C316-4688-ACAF-51A72BEFFC24 Q30365734-A6DDAE99-5214-469F-8253-12B53CDFAAE9 Q30380655-54B1A559-793A-4076-A172-9DE89B2D7D57 Q30437131-1CF70107-A6E7-4303-8FB9-6BB2FB05A5B1 Q30443312-6A6B65DF-305C-4355-8CA1-9FB16F8024F1 Q30443330-4329381B-FFBB-4EEE-B2E4-961B295FD4DA Q30484255-0EAB3A51-5E5A-4A16-84C2-41F9E1C71544 Q30493579-C58FAAF1-A0ED-4136-A357-AE8DCBD9C28A Q30503518-69F110BB-EF88-4E08-A202-4A0D4A2D0DFC Q30523072-C62D39F1-F6DF-457C-A8A1-784D000F3BD2 Q30625922-D2DF2B2F-EC78-4820-9278-1F66BFF89317 Q30832319-D65FF064-D4E5-4FCB-91F5-8CC9169D5488 Q30849505-715CD5BA-957A-4D81-A200-EE42C2786C17 Q30863868-786F0B5F-2042-4DC5-84EA-744278ED39B4 Q31035125-94736F57-9293-4635-AFDF-F9250948268E Q31149897-3485C4DE-3B5D-46B4-B1F9-6F55A6740A0B Q33515877-819F0F17-C0C7-41E9-971B-C25886E0BC77 Q33570944-B3ECBFF7-CA27-4EBE-8B86-5FE026F784A4 Q33718596-263DBCE3-0EB8-4DFF-B0AA-DA46ED1EC920 Q33727172-5F458D90-003C-4DD0-A438-D4D5A859CE08 Q33778539-B1BB5C0D-8BAC-4197-8F48-5128934747BE Q33821715-4CB7DA7D-434E-43EF-96B1-0DA232500455 Q33893017-F623D731-4F2E-4717-9971-59F675B5516B Q33896874-412721DC-5CB5-4EAC-BCBA-EA210899B06F Q33906596-64DF76E2-4857-4C2F-8587-001BCDFE22FA Q33984004-F9AD7B5C-56DA-4000-93A5-22B9E97E5591 Q34003950-76CDDC53-DEC5-4205-99BB-C248A346FDE1 Q34097620-E5854B6C-D7E0-46F9-869F-664AFC124EAB

P2860

Kinetic theory of fibrillogenesis of amyloid beta-protein.

http://www.wikidata.org/entity/Q36298130

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Kinetic theory of fibrillogenesis of amyloid beta-protein.

@ast

Kinetic theory of fibrillogenesis of amyloid beta-protein.

@en

type

label

Kinetic theory of fibrillogenesis of amyloid beta-protein.

@ast

Kinetic theory of fibrillogenesis of amyloid beta-protein.

@en

prefLabel

Kinetic theory of fibrillogenesis of amyloid beta-protein.

@ast

Kinetic theory of fibrillogenesis of amyloid beta-protein.

@en

P1433

Q36298130-BE1F7801-3A0D-4F72-BF6F-A0A5403EB5BF

P1476

Q36298130-3E1131D1-9666-4D16-A173-7742AEFA3D5E

P2093

Q36298130-017F5CBD-CDFE-4631-B895-A93C15705C4F

Q36298130-8ECD007B-DD96-422B-B773-03ABC19EC9B7

Q36298130-D1875142-0790-435A-9A8B-85EFBFAAFFB4

Q36298130-E336DA5F-5ECC-4BFE-8E0B-A1F71C5AB27B

P2860

Q36298130-04AC9B82-5ACB-4E2D-B0EA-CA5DF41BC8C9

Q36298130-10681FBB-166F-472C-B282-121A979C8A68

Q36298130-1273D12E-D704-4C6C-ABF3-26CFBB52E99B

Q36298130-18DBE7B0-B319-4817-8E83-4D7B5F7A91AE

Q36298130-39D21333-75DA-428C-8D71-2CBF783FC70F

Q36298130-3BEF8270-DD4E-4F40-9A79-EF87FD8ED495

Q36298130-4DCDE03A-F17E-4613-957A-04DDEF5D01B7

Q36298130-6987148E-5F6D-42A7-A86D-B81AAA4540D2

Q36298130-712EDD0B-6914-4820-B3E2-1D5F6D01C1B9

Q36298130-77893BF7-7D77-4966-B189-9DFB1F893C7F

P304

Q36298130-B05760F0-9E5B-473F-9091-5A467D2A79DF

P31

Q36298130-1E117F96-9B4C-430C-8EAA-FB69D163DA13

P356

Q36298130-A662DB39-81F2-431B-9537-5D32F587E011

P407

Q36298130-595B17BD-6342-4AE8-ACF1-6853B1BE1934

P433

Q36298130-5FBB4F8A-4902-4C7D-9CD5-942137AD0D3F

P478

Q36298130-2EABAD4F-CD9B-4845-8BA2-92D1854F68CA

P577

Q36298130-44B13451-6DF8-4910-8C79-83C511F03046

P5875

Q36298130-98A6E7A4-DD1B-4702-A049-47C4267007B2

P698

Q36298130-5FC4EBE2-1A06-496D-8F45-3915356B01FF

P932

Q36298130-CD64EB6F-D09B-4D2C-805C-EE6C0F190371

P356

PNAS.94.15.7942

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Kinetic theory of fibrillogenesis of amyloid beta-protein.

@en

P2093

A Lomakin

http://www.w3.org/2001/XMLSchema#string

D A Kirschner

http://www.w3.org/2001/XMLSchema#string

D B Teplow

http://www.w3.org/2001/XMLSchema#string

G B Benedek

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.

Hydrodynamic properties of complex, rigid, biological macromolecules: theory and applications.

Alzheimer's disease: a central role for amyloid.

Mechanisms of neuronal degeneration in Alzheimer's disease.

Alzheimer's disease: genotypes, phenotypes, and treatments.

Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.

Solvent effects on self-assembly of beta-amyloid peptide

P304

7942-7947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.15.7942

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13996892

http://www.w3.org/2001/XMLSchema#string

P698

9223292

http://www.w3.org/2001/XMLSchema#string

P932

21534

http://www.w3.org/2001/XMLSchema#string